Use of Gabapentin in the Prevention of Taxane-Induced Arthralgias and Myalgias
Author:
Affiliation:
1. University of California San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.99.298
Reference17 articles.
1. Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
2. Jacobson S, Loprinzi C, Sloan J, et al: Glutamine for preventing paclitaxel-associated myalgias and arthralgias: Unfortunately a “no go.” Proc Am Soc Clin Oncol 21:366a,2002, (abstr 1460)
3. Glutamine treatment of paclitaxel-induced myalgias and arthralgias.
4. Fujiwara H: Prevention of arthralgias and myalgias from paclitaxel and CBDCA combination chemotherapy with Shakuyaku-Kanzo-To and L-glutamine. Proc Am Soc Clin Oncol 20:299b,2001, (abstr 2948)
5. Effects of Shakuyaku-kanzo-to on Muscle Pain from Combination Chemotherapy with Paclitaxel and Carboplatin
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessing the effectiveness of gabapentin in paclitaxel-induced arthralgia, myalgia, and neuropathic pain: An observational, cohort study;Journal of Oncology Pharmacy Practice;2024-01-05
2. Dexamethasone dose-dependently prevents taxane-associated acute pain syndrome in breast cancer treatment;Supportive Care in Cancer;2023-06
3. Prevention and therapy of chemotherapy-induced peripheral neuropathy: a review of recent findings;Neoplasma;2023
4. Aroma lymphatic massage (Aroma lymphatic tressage) for symptom relief in breast cancer patients with taxane acute pain syndrome: A randomized controlled crossover trial;European Journal of Integrative Medicine;2022-09
5. Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial;European Journal of Cancer;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3